Peptron, Inc. (KOSDAQ:087010)
South Korea · Delayed Price · Currency is KRW 184,400
+1,300 (0.71%)
Aug 11, 2026, 3:30 PM KST
Peptron Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 5,981 | 5,635 | 3,152 | 3,342 | 5,814 | 6,625 |
Revenue Growth | 39.25% | 78.76% | -5.68% | -42.52% | -12.23% | 112.28% |
Gross Profit Gross Profit Growth | 849.12 | 1,342 | 937.45 | 1,054 | 3,271 | 4,466 |
Operating Income Operating Income Growth | -22,683 | -21,257 | -16,528 | -15,884 | -15,227 | -15,659 |
Net Income Net Income Growth | -16,617 | -13,824 | -22,034 | -15,922 | -15,063 | -15,042 |
Earnings Per Share EPS Growth | -715.21 | -595.09 | -1061.00 | -774.00 | -730.00 | -729.00 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Bio Bio Growth | 2,205 | 2,283 | 4,545 | 5,119 | 1,678 |
Pharmaceutical Pharmaceutical Growth | 947.25 | 1,059 | 1,269 | 1,505 | 1,442 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 83,643 | 106,918 | 123,897 | 4,983 | 17,243 | 30,236 |
Total Debt Total Debt Growth | 30,102 | 29,555 | 9,236 | 9,133 | 9,226 | 9,156 |
Net Cash (Debt) Net Cash Growth | 53,540 | 77,363 | 114,661 | -4,150 | 8,017 | 21,080 |
Net Cash Growth | -49.64% | -32.53% | - | - | -61.97% | -39.17% |
Net Cash Per Share Net Cash Per Share Growth | 2304.43 | 3326.00 | 5521.33 | -201.75 | 388.53 | 1021.62 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -20,526 | -20,586 | -12,766 | -10,973 | -11,720 | -10,615 |
Capital Expenditures CapEx Growth | -9,128 | -2,494 | -1,008 | -731.09 | -1,525 | -698.6 |
Free Cash Flow Free Cash Flow Growth | -29,654 | -23,080 | -13,775 | -11,705 | -13,245 | -11,313 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 14.20% | 23.82% | 29.74% | 31.53% | 56.26% | 67.42% |
Operating Margin | -379.24% | -377.25% | -524.33% | -475.30% | -261.90% | -236.37% |
Pretax Margin | -286.23% | -254.25% | -685.85% | -477.00% | -259.15% | -230.71% |
Profit Margin | -277.82% | -245.33% | -699.00% | -476.43% | -259.08% | -227.07% |
FCF Margin | -495.78% | -409.60% | -436.99% | -350.24% | -227.81% | -170.78% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 718.87 | 1051.07 | 752.39 | 248.43 | 27.14 | 34.56 |